Following promising clinical results, retatrutide, a novel peptide therapy for addressing type 2 metabolic disorder, has secured regulatory approval from UK’s Medicines and Regulatory Agency ( MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/